Xiaoming Xu from the Office of Pharmaceutical Quality discusses common issues and considerations in the development and validation of an analytical method for particle size characterization.
Learn more at https://www.fda.gov/drugs/regulatory-education-industry-advancing-innovative-science-generic-drug-development-workshop
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training – https://www.fda.gov/cdersbia
SBIA Listserv – https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_352
SBIA 2020 Playlist – https://www.youtube.com/playlist?list=PLey4Qe-UxcxZiTopt4biuIyxmUQJDkaWb
SBIA LinkedIn – https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
SBIA Training Resources – https://www.fda.gov/cderbsbialearn
Twitter – https://twitter.com/FDA_Drug_Info
Email – CDERSBIA@fda.hhs.gov
Phone – (301) 796-6707 I (866) 405-5367